Literature DB >> 27044296

Fatigue randomized controlled trials-how tired is "too tired" in patients undergoing glioma treatment?

Robin Grant1, Paul D Brown1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27044296      PMCID： PMC4864267          DOI： 10.1093/neuonc/now052

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  11 in total

1.  Phase II double-blind placebo-controlled randomized study of armodafinil for brain radiation-induced fatigue.

Authors:  Brandi R Page; Edward G Shaw; Lingyi Lu; David Bryant; David Grisell; Glenn J Lesser; Drew C Monitto; Michelle J Naughton; Stephen R Rapp; Steven R Savona; Sunjay Shah; Doug Case; Michael D Chan
Journal:  Neuro Oncol       Date:  2015-05-12       Impact factor: 12.300

2.  A randomized trial on the efficacy of methylphenidate and modafinil for improving cognitive functioning and symptoms in patients with a primary brain tumor.

Authors:  K Gehring; S Y Patwardhan; R Collins; M D Groves; C J Etzel; C A Meyers; J S Wefel
Journal:  J Neurooncol       Date:  2011-10-02       Impact factor: 4.130

3.  Risk factors for fatigue severity in primary brain tumor patients.

Authors:  Terri S Armstrong; Stanley G Cron; Elizabeth Vera Bolanos; Mark R Gilbert; Duck-Hee Kang
Journal:  Cancer       Date:  2010-06-01       Impact factor: 6.860

Review 4.  Origin of fatigue in multiple sclerosis: review of the literature.

Authors:  D Kos; E Kerckhofs; G Nagels; M B D'hooghe; S Ilsbroukx
Journal:  Neurorehabil Neural Repair       Date:  2007-04-04       Impact factor: 3.919

5.  Cognitive rehabilitation and problem-solving to improve quality of life of patients with primary brain tumors: a pilot study.

Authors:  Dona E C Locke; Jane H Cerhan; Wenting Wu; James F Malec; Matthew M Clark; Teresa A Rummans; Paul D Brown
Journal:  J Support Oncol       Date:  2008 Nov-Dec

6.  Phase II study of donepezil in irradiated brain tumor patients: effect on cognitive function, mood, and quality of life.

Authors:  Edward G Shaw; Robin Rosdhal; Ralph B D'Agostino; James Lovato; Michelle J Naughton; Michael E Robbins; Stephen R Rapp
Journal:  J Clin Oncol       Date:  2006-03-20       Impact factor: 44.544

7.  Cognitive rehabilitation in patients with gliomas: a randomized, controlled trial.

Authors:  Karin Gehring; Margriet M Sitskoorn; Chad M Gundy; Sietske A M Sikkes; Martin Klein; Tjeerd J Postma; Martin J van den Bent; Guus N Beute; Roelien H Enting; Arnoud C Kappelle; Willem Boogerd; Theo Veninga; Albert Twijnstra; Dolf H Boerman; Martin J B Taphoorn; Neil K Aaronson
Journal:  J Clin Oncol       Date:  2009-05-26       Impact factor: 44.544

8.  The effect of modafinil on fatigue, cognitive functioning, and mood in primary brain tumor patients: a multicenter randomized controlled trial.

Authors:  Florien W Boele; Linda Douw; Marjolein de Groot; Hinke F van Thuijl; Wilmy Cleijne; Jan J Heimans; Martin J B Taphoorn; Jaap C Reijneveld; Martin Klein
Journal:  Neuro Oncol       Date:  2013-08-07       Impact factor: 12.300

9.  A phase III, double-blind, placebo-controlled prospective randomized clinical trial of d-threo-methylphenidate HCl in brain tumor patients receiving radiation therapy.

Authors:  Jerome M Butler; L Douglas Case; James Atkins; Bart Frizzell; George Sanders; Patricia Griffin; Glenn Lesser; Kevin McMullen; Richard McQuellon; Michelle Naughton; Stephen Rapp; Volker Stieber; Edward G Shaw
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-09-14       Impact factor: 7.038

Review 10.  Interventions for the management of fatigue in adults with a primary brain tumour.

Authors:  Julia Day; Shlomit Yust-Katz; David Cachia; Jeffrey Wefel; Lior H Katz; Ivo Tremont; Helen Bulbeck; Terri Armstrong; Alasdair G Rooney
Journal:  Cochrane Database Syst Rev       Date:  2016-04-13
View more
  5 in total

Review 1.  Interventions for the management of fatigue in adults with a primary brain tumour.

Authors:  Julia Day; Shlomit Yust-Katz; David Cachia; Jeffrey Wefel; Ivo W Tremont Lukats; Helen Bulbeck; Alasdair G Rooney
Journal:  Cochrane Database Syst Rev       Date:  2022-09-12

2.  Clinical activity and safety of atezolizumab in patients with recurrent glioblastoma.

Authors:  Rimas V Lukas; Jordi Rodon; Kevin Becker; Eric T Wong; Kent Shih; Mehdi Touat; Marcella Fassò; Stuart Osborne; Luciana Molinero; Carol O'Hear; William Grossman; Joachim Baehring
Journal:  J Neurooncol       Date:  2018-08-02       Impact factor: 4.130

3.  Screening for distress in patients with intracranial tumors during the first 6 months after diagnosis using self-reporting instruments and an expert rating scale (the basic documentation for psycho-oncology short form - PO-Bado SF).

Authors:  Mirjam Renovanz; Helena Tsakmaklis; Sari Soebianto; Isabell Neppel; Minou Nadji-Ohl; Manfred Beutel; Andreas Werner; Florian Ringel; Anne-Katrin Hickmann
Journal:  Oncotarget       Date:  2018-07-24

4.  Metabolic derangements of skeletal muscle from a murine model of glioma cachexia.

Authors:  Pengfei Cui; Wei Shao; Caihua Huang; Chang-Jer Wu; Bin Jiang; Donghai Lin
Journal:  Skelet Muscle       Date:  2019-01-11       Impact factor: 4.912

5.  A phase III double-blind placebo-controlled randomized study of dexamphetamine sulfate for fatigue in primary brain tumors patients: An ANOCEF trial (DXA).

Authors:  Florence Laigle-Donadey; François Ducray; Matthieu Boone; Mamadou Hassimiou Diallo; David Hajage; Carole Ramirez; Olivier Chinot; Damien Ricard; Jean-Yves Delattre
Journal:  Neurooncol Adv       Date:  2019-11-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.